Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson’s Disease

Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson’s Disease

The motor and nonmotor symptoms of Parkinson’s disease (PD) correlate with the formation and propagation of aberrant α-synuclein aggregation. This protein accumulation is a pathological hallmark of the disease. Our group recently showed that peucedanocoumarin III (PCIII) possesses...

Full description

Bibliographic Details
Main Authors: Sangwoo Ham, Heejeong Kim, Jin-Ha Yoon, Hyojung Kim, Bo Reum Song, Jeong-Yun Choi, Yun-Song Lee, Seung-Mann Paek, Han-Joo Maeng, Yunjong Lee
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:International Journal of Molecular Sciences
Subjects:
peucedanocoumarin iii
organic synthesis
parkinson’s disease
distribution
α-synuclein aggregation
dopaminergic cell loss
Online Access:https://www.mdpi.com/1422-0067/20/21/5481

Internet

https://www.mdpi.com/1422-0067/20/21/5481

Similar Items